Sleep medicine
The most recent articles from:
Sleep Med.
-
Randomized Controlled Trial Clinical Trial
A prospective 8 week trial of nasal interfaces vs. a novel oral interface (Oracle) for treatment of obstructive sleep apnea hypopnea syndrome.
To compare efficacy, compliance rates, and side effects of a new strapless oral interface, the Oracle, with available nasal masks over 8 weeks of use for the treatment of obstructive sleep apnea hypopnea syndrome (OSAHS). ⋯ Oral delivery of CPAP with the Oracle is an effective and suitable alternative for patients with OSAHS.